Immunotherapy Against Lung Cancers

图书简介

This book provides insight into the various immunotherapeutic approaches for the treatment of lung cancers. The chapters of the book discuss the detailed mechanisms of checkpoint inhibitors, co-stimulatory molecules, drugs working in the immunosuppressive environment, and various vaccines for lung cancer. A chapter of the book explores the recent applications of the oncolytic virus in lung cancer treatment and discusses the potential and direction of oncolytic virus-based therapeutic vaccines. The chapter also elucidates the current understanding of the role of Toll-Like Receptors (TLRs) in tumor progression, and the recent progress in utilizing TLR agonists as potential therapeutic agents in lung cancer treatment. Towards the end, the book reviews the applications of stereotactic body radiation therapy (SBRT) and immunotherapy for the treatment of lung cancer. This book provides useful information to a range of audiences including clinical researchers working in the field of lung cancer, and undergraduate and postgraduate students from various disciplines such as pharmacy, microbiology, immunology, pharmacology, biotechnology, and health sciences.

Chapter 1_An introduction to Lung cancer.- Chapter 2_Immunobiology of Lung cancer.- Chapter 3_Evolution of Lung cancer treatment from classical chemotherapy to advanced immunotherapy.- Chapter 4_Recent advances in the immunotherapy of Lung cancer.- Chapter 5_PD-1/PD-L1 inhibitors for the treatment of Lung cancer.- Chapter 6_CTLA-4 inhibitors for the treatment of Lung cancer.- Chapter 7_Adoptive T cell therapy for the treatment of Lung cancer.- Chapter 8_LAG-3 inhibitors for the treatment of Lung cancer.- Chapter 9_IDO and TGF-β inhibitors for the treatment of Lung cancer.- Chapter 10_OX40 and CD40 agonists for the treatment of Lung cancer.- Chapter 11_ICOS and GITR agonists for the treatment of Lung cancer.- Chapter 12_Vaccines and oncolytic virus for the treatment of Lung cancer.- Chapter 13_Targeting Toll-like receptors for the treatment of Lung cancer.- Chapter 14_Current and future perspectives of combining chemotherapy and stereotactic body radiation therapy with immunotherapy.- Chapter 15_Synergistic potential of PD-1/PD-L1 inhibitors and CTLA-4 inhibitors for the treatment of Lung cancer.- Chapter 16_Synergistic potential of antigen-specific vaccines and immunomodulatory agents for the treatment of Lung cancer.- Chapter 17_Important biomarkers for better evaluation of checkpoint inhibitors and another immunotherapy in Lung cancer.- Chapter 18_Insight on the clinical trials of immunotherapy for the treatment of Lung cancer.- Chapter 19_Future perspectives of the Cancer Immunotherapy for the treatment of Lung cancer.

Trade Policy 买家须知

关于产品：
● 正版保障：本网站隶属于中国国际图书贸易集团公司，确保所有图书都是100%正版。
● 环保纸张：进口图书大多使用的都是环保轻型张，颜色偏黄，重量比较轻。
● 毛边版：即书翻页的地方，故意做成了参差不齐的样子，一般为精装版，更具收藏价值。
关于退换货：
由于预订产品的特殊性，采购订单正式发订后，买方不得无故取消全部或部分产品的订购。
由于进口图书的特殊性，发生以下情况的，请直接拒收货物，由快递返回：
● 外包装破损/发错货/少发货/图书外观破损/图书配件不全（例如：光盘等）
并请在工作日通过电话400-008-1110联系我们。
签收后，如发生以下情况，请在签收后的5个工作日内联系客服办理退换货：
● 缺页/错页/错印/脱线
关于发货时间：
一般情况下：
●【现货】下单后48小时内由北京（库房）发出快递。
●【预订】【预售】下单后国外发货，到货时间预计5-8周左右，店铺默认中通快递，如需顺丰快递邮费到付。
● 需要开具发票的客户，发货时间可能在上述基础上再延后1-2个工作日（紧急发票需求，请联系010-68433105/3213）；
● 如遇其他特殊原因，对发货时间有影响的，我们会第一时间在网站公告，敬请留意。
关于到货时间：
由于进口图书入境入库后，都是委托第三方快递发货，所以我们只能保证在规定时间内发出，但无法为您保证确切的到货时间。
● 主要城市一般2-4天
● 偏远地区一般4-7天
关于接听咨询电话的时间：
010-68433105/3213正常接听咨询电话的时间为：周一至周五上午8：30～下午5：00，周六、日及法定节假日休息，将无法接听来电，敬请谅解。
其它时间您也可以通过邮件联系我们：customer@readgo.cn,工作日会优先处理。
关于快递：
● 已付款订单：主要由中通、宅急送负责派送，订单进度查询请拨打010-68433105/3213。

Immunotherapy Against Lung Cancers 肺癌免疫疗法：新出现的机遇与挑战 肿瘤学

Immunotherapy Against Lung Cancers

肺癌免疫疗法：新出现的机遇与挑战
肿瘤学